StockUK listing UKEMVCLSEFinancial ServicesBalanced

EMV Capital plc(EMVC) Stock Analysis | Financial Services

GBX --+0.00%
Reward49Moderate
Risk56Medium-High
75%Data
Strong 622% profit margin · Revenue growing 22% YoY
GBX —+0.00 (+0.00%) Previous close · LSE
Market cap 13.14M
Reward Ratingⓘ49 Moderate reward assessment · 75% data coverage
Bottom 50% of stocksView factors
Risk Ratingⓘ56 Medium-High risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on EMVC to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is EMV Capital plc?

EMV Capital plc is a venture capital firm specializing in seed, growth capital, early and mid stage investments.

AI Brief Pro

The brief on EMV Capital plc

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is EMV Capital plc?

EMV Capital plc is a venture capital firm specializing in seed, growth capital, early and mid stage investments. The firm focuses to invest in sustainability, life science, technology, transformative biomedical, deep tech, semiconductors, industrials, robotics, AI and healthcare technologies focusing on digital health, diagnostics, and therapeutics sectors. The company is listed on the LSE in UK, operating in the Financial Services sector, with a market capitalisation of 13.14M, and a P/E ratio of 0.7x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Profitability metrics are mixed — margins may be under pressure.
Risk
Performance tied to macro conditions — sensitive to interest rate cycles.
Valuation
Discount reflects uncertainty around future performance.

OpenBook Logo Analysis

Reward: Moderate (49)
Company Information
IndustryAsset Management
P/E Ratio0.6812
Beta0.559
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.